Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Neuroendocrine Cancer UK Hero Awards Winners!

Neuroendocrine Cancer UK Hero Awards Winners!

Neuroendocrine Cancer UK proudly launched the Neuroendocrine Cancer UK Hero Awards in September 2024, an initiative designed to honour the courage and resilience of neuroendocrine cancer patients, the unwavering dedication of medical professionals, the steadfast...

read more
Our latest update on PERT – Dec 2024

Our latest update on PERT – Dec 2024

Our latest update on PERT We have been working with our community and fellow charities to continue to seek solutions to current PERT supply issues. Our collaborative working group of charities and patient organisations continues to meet monthly - here is this...

read more